Merck withdrew a Cox-2 drug.
The pharmaceutical maker was announced Friday.
The Vioxx withdrawal caused Merck third quarter profit to fall 29 percent.
Merck shares rose 29 cents at $31.86.
Further safety and efficacy data before it will approve Merck &amp; Co.
The agency will convene a panel of outside experts to review an evidence.
Health Canada asked Pfizer.
Vioxx safety concerns were continued to mount to mount after 2000.
A copy of the letter from Chuck Grassley declined comment.
Email provided fda spokeswoman Kathleen Quinn.
The FDA released an September 30 memo from David Graham.
